The Role of 4-24 Micron Far Infrared Heat & Ultrasound Waves in the Topical Absorption of Cannabinoid-Based Drugs



Abstract Views
423

Downloads
245

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Jun 20, 2022
Published Aug 1, 2022
10.24018/ejmed.2022.4.4.1393

Abstract viewed = 423 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

The best way to deliver a drug in pursuit of maximum potential is to deliver it with maximal bioavailability. There are many options in delivering a drug, but each way reduces the drug's bioavailability differently. For treating localized discomfort, the transdermal approach or the topical approach is considered to be an advantageous one mainly because of its rapid localized action and the fewest side effects associated with this route. Drug delivery through topicals is an easy-to-reach approach and, in most cases, bypasses the first-pass metabolism. However, under certain conditions, the drug either needs to be delivered in its unaffected, concentrated form or needs to be delivered deeper into the dermal layers of the skin with immediate effect. This paper will review and suggest all those possible ways through which topical drug delivery can be universally enhanced in rate, effectiveness, and efficiency. Specialized ultrasound waves and sub-spectrum far-infrared heat help accelerate and deliver topical ingredients to the site of action. Making this the basis of our argument, we shall see in detail why they help achieve the desired results and why both these methods should be adapted in a combined approach to deliver the drug to the precise site of action through the topical or transdermal approach. Furthermore, Cannabidiol (CBD) is a model drug in this paper due to its faster absorption rate and outnumbered measurable benefits.

Keywords: Cannabis, heat, infrared radiation, topical drug delivery, ultrasound

Downloads

Download data is not yet available.

References

  1. British Medical Association. Therapeutic uses of cannabis. CRC Press, 1997.
     Google Scholar
  2. ElSohly M, Gul W. Constituents of Cannabis sativa. Handbook of Cannabis. 2014; 3: 1093.
    DOI  |   Google Scholar
  3. Huestis MA. Human cannabinoid pharmacokinetics. Chemistry & biodiversity. 2007; 4(8): 1770.
    DOI  |   Google Scholar
  4. Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use–basic prevalence and related health outcomes: A scoping review and synthesis. International Journal of Drug Policy. 2018; 52: 87-96.
    DOI  |   Google Scholar
  5. Ruela AL, Perissinato AG, Lino ME, Mudrik PS, Pereira GR. Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian Journal of Pharmaceutical Sciences. 2016; 52: 527-44.
    DOI  |   Google Scholar
  6. Mahmoudinoodezh H, Telukutla SR, Bhangu SK, Bachari A, Cavalieri F, Mantri N. The Transdermal Delivery of Therapeutic Cannabinoids. Pharmaceutics. 2022; 14(2): 438.
    DOI  |   Google Scholar
  7. Benson HA, Grice JE, Mohammed Y, Namjoshi S, Roberts MS. Topical and transdermal drug delivery: from simple potions to smart technologies. Current Drug Delivery. 2019; 16(5): 444-60.
    DOI  |   Google Scholar
  8. Scholfield CN, Waranuch N, Kongkaew C. Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward. Cannabis and Cannabinoid Research. 2022.
    DOI  |   Google Scholar
  9. Oberli MA, Schoellhammer CM, Langer R, Blankschtein D. Ultrasound-enhanced transdermal delivery: recent advances and future challenges. Ther Deliv. 2014; 5(7): 843-857.
    DOI  |   Google Scholar
  10. Tang H, Wang CC, Blankschtein D, Langer R. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharmaceutical Research. 2002; 19(8): 1160-9.
    DOI  |   Google Scholar
  11. Carvell KJ, Bigelow TA. Dependence of optimal seed bubble size on pressure amplitude at therapeutic pressure levels. Ultrasonics. 2011; 51(2): 115-22.
    DOI  |   Google Scholar
  12. Hao J, Ghosh P, Li SK, Newman B, Kasting GB, Raney SG. Heat effects on drug delivery across human skin. Expert Opinion on Drug Delivery. 2016; 13(5): 755-68.
    DOI  |   Google Scholar
  13. Szunerits S, Boukherroub R. Heat: a highly efficient skin enhancer for transdermal drug delivery. Frontiers in Bioengineering and Biotechnology 6. 2018: 15.
    DOI  |   Google Scholar
  14. Wall PD, Fry WJ, Stephens R, Tucker D, Lettvin JY. Changes produced in the central nervous system by ultrasound. Science. 1951; 114(2974): 686-7.
    DOI  |   Google Scholar
  15. Vatansever F, Hamblin MR. Far infrared radiation (FIR): its biological effects and medical applications. Photonics & Lasers in Medicine. 2012; 1(4): 255-66.
    DOI  |   Google Scholar
  16. Yu SY, Chiu JH, Yang SD, Hsu YC, Lui WY, Wu CW. Biological effect of far‐infrared therapy on increasing skin microcirculation in rats. Photodermatology, Photoimmunology & Photomedicine. 2006;22(2):78-86.
    DOI  |   Google Scholar
  17. Park D, Park H, Seo J, Lee S. Sonophoresis in transdermal drug deliverys. Ultrasonics. 2014; 54(1): 56-65.
    DOI  |   Google Scholar
  18. Lin Y-H, Li T-S. The Application of Far-Infrared in the Treatment of Wound Healing: A Short Evidence-Based Analysis. Journal of Evidence-Based Complementary & Alternative Medicine. 2017: 186-188.
    DOI  |   Google Scholar